Pfizer Stock News

The first-of-its-kind treatment, Paxlovid, has been found to be highly protective against severe illness. It could be available within a few days.

Paxlovid will be able to be taken at home to head off the worst effects of the virus; is first non-injection treatment for COVID-19 given the okay by the FDA

The U.S. Food and Drug Administration on Wednesday authorized the emergency use of Paxlovid, Pfizer Inc''s (NYSE: PFE ) COVID-19 oral antiviral treatment. "Given the circumstances that we are dealing with right now I think this is huge," Market Rebellion co-founder Pete Najarian said on CNBC''s "Fast Money Halftime Report." See Also: Pfizer''s Paxlovid Scores FDA Approval, First Oral Antiviral For COVID-19 In US Health officials have warned the surge in COVID-19 cases could continue as people begin traveling for the holidays due to the omicron variant''s heightened transmissibility. Investors have been anticipating the authorization of PAXLOVID, the first drug that ... Full story available on Benzinga.com

Cambridge Investment Research Advisors Inc. reduced its holdings in Pfizer Inc. (NYSE:PFE) by 8.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,463,217 shares of the biopharmaceutical companys stock after selling 126,671 shares during the period. Cambridge Investment Research []

Pfizer says the FDA authorized its antiviral COVID-19 pill, making it the first at-home treatment for the coronavirus.

The Food and Drug Administration has authorized a new pill from Pfizer that the company says cuts the risk of hospitalization and death in coronavirus patients by 89 percent.

Pfizer’s Paxlovid tablets against Covid have been given emergency use authorization by the US Food and Drug Administration (FDA). The first pill treatment of this kind, it can be prescribed to high-risk patients aged 12 and older. Read Full Article at RT.com

The FDA on Wednesday authorized the first Covid-19 antiviral pill for emergency use. The Pfizer drug, called Paxlovid, will be prescribed for use in adults and children over the age of 12 with mild to moderate sickness who are at risk for severe disease or hospitalization. The authorization marks a major step forward, director of [] The post FDA Authorizes Pfizer COVID Pill for Emergency Use appeared first on Human Events .

Thousands of courses of Pfizer''s pills could be available this month.

The US Food and Drug Administration (FDA) on Wednesday authorized Pfizer''s Covid pill for high-risk people aged 12 and over, a major milestone in the pandemic that will allow millions to access the treatment.

The Food and Drug Administration has authorized the first of two different COVID-19 treatment pills Wednesday. The pill is called Paxlovid, and is made by Pfizer.

The Food and Drug Administration on Wednesday authorized Paxlovid, a pill developed and made by Pfizer, as a treatment for Covid-19, a significant step in the battle against the SARS-CoV-2 virus.

The Food and Drug Administration authorized Pfizer''s Covid-19 antiviral pill for emergency use.

US health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus.

The Food and Drug Administration (FDA) on Wednesday authorized a new COVID-19 treatment from Pfizer, the first pill to treat the virus to become available.The pill, known as Paxlovid, is seen as a major step forward in the fight against the